OKLO
A reactor milestone, then a market shrug
Oklo had one of those news days that should feel like a victory lap and a stress test at the same time. The company’s Groves test reactor hit first criticality on August 5th, a big technical milestone that suggests the company can actually do the nuclear-rocket-ship thing it keeps promising.
Why investors cared
HC Wainwright’s Sameer Joshi said the milestone matters because it came from a company-owned, non-government facility, was built fast, and adds real-world engineering proof points. Translation: it doesn’t magically hand Oklo approval, but it does make the path look a little less like a moonshot and a little more like a route with pavement.
The analyst reiterated a Buy rating and slapped a $90 price target on the stock. That’s the bullish headline. The less shiny part? Oklo’s operating expenses jumped 44% sequentially to $73.7 million, net loss widened to $48.5 million, and management lifted full-year spending plans again.
The part that may matter even more
There was also a fresh Letter of Intent with Centrus Energy to supply fuel for as many as five Aurora powerhouses. That’s not the same as revenue booked in the bank, but it does show Oklo is stitching together the parts of a future commercial business.
- Operating expenses: up fast
- Cash burn outlook: higher
- Capital spending: higher still
- Reactor milestone: real, and potentially de-risking
Big picture: Oklo is still in the expensive, pre-payoff phase of the nuclear story. But every technical win makes the eventual approval and commercialization narrative a little less sci-fi and a little more spreadsheet-ready.